Approval · Notice of Compliance 21650 · 2018
RUBY-FILL: Notice of Compliance 21650
Issued December 21, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21650
- Date
- December 21, 2018
- Company
- Jubilant Draximage Inc.Kirkland, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- An alternative source of strontium (sr-82) chloride
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RUBY-FILL | Not yet assigned | — |
Medicinal ingredients
- RUBIDIUM CHLORIDE RB 82 3.7 GBQ per UNIT